Filing Flows › Comparisons › OMER vs LFCR
Omeros vs Lifecore Biomedical: OMER and LFCR compared
Omeros is the larger company: $28.5M of revenue in its latest quarter (Q2 2026) against $25.3M for Lifecore Biomedical (Q1 FY27). Omeros is more profitable, with an operating margin of 0.3% against -3.5%.
Where the money goes: OMER and LFCR
Omeros (OMER) · Q2 2026
Omeros, Q2 2026: revenue $28.5M, operating margin 0.3%, net earnings $13.2M, operating cash flow $4.1M. The chart follows the revenue to costs, profit and cash.
Lifecore Biomedical (LFCR) · Q1 FY27
Lifecore Biomedical, Q1 FY27: revenue $25.3M (-19% year over year), operating margin -3.5%, net loss $40.1M, operating cash flow $6.9M. The chart follows the revenue to costs, profit and cash.
| Omeros (OMER) | Lifecore Biomedical (LFCR) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q1 FY27 |
| Revenue | $28.5M | $25.3M |
| Revenue growth, Y/Y | — | -19% |
| Operating margin | 0.3% | -3.5% |
| Net earnings | $13.2M | −$40.1M |
| Net margin | 46.4% | -158.3% |
| Operating cash flow | $4.1M | $6.9M |
| Free cash flow | $4.1M | $6.0M |
| Market value | $1.8B | — |
| P/E | 14.4× | — |
| Analysts’ mean target | $27.50 | — |
Where the revenue comes from
Lifecore Biomedical
- CDMO: $17.8M (70%)
- HA manufacturing: $7.5M (30%)
Questions
Which is bigger, Omeros or Lifecore Biomedical?
Omeros is the larger company: $28.5M of revenue in its latest quarter (Q2 2026) against $25.3M for Lifecore Biomedical (Q1 FY27).
Is Omeros or Lifecore Biomedical growing faster?
Omeros is more profitable, with an operating margin of 0.3% against -3.5%.
More: Omeros earnings · how Omeros makes money · Lifecore Biomedical earnings · how Lifecore Biomedical makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 12, 2026; 10-Q filed Nov 4, 2026). Fiscal quarters can end on different dates. Not investment advice.